ArticleClinicoEconomics and outcomes research : CEOR2018

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.

Dhvani Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.